Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Quest Diagnostics, Inc shares valued at $968,625 were sold by Plewman Patrick on Aug 06 ’25. At $175.00 per share, Plewman Patrick sold 5,535 shares. The insider’s holdings dropped to 19,219 shares worth approximately $3.44 million following the completion of this transaction.
Also, Plewman Patrick purchased 5,535 shares, netting a total of over 968,625 in proceeds.
Before that, KUPPUSAMY KARTHIK had sold 8,269 shares from its account. In a trade valued at $1,384,231, the SVP, Clinical Solutions traded Quest Diagnostics, Inc shares for $167.40 each. Upon closing the transaction, the insider’s holdings decreased to 8,269 shares, worth approximately $1.91 million.
As published in their initiating research note from Redburn Atlantic on April 02, 2025, Quest Diagnostics, Inc [DGX] has been a Buy and the price target has been revised to $195. Analysts at Citigroup downgraded the stock from ‘”a Buy”‘ to ‘”a Neutral”‘ outlook in a report released in early March. As of January 06, 2025, Leerink Partners has increased its “Market perform” rating to a “an Outperform” for DGX. Earlier on December 17, 2024, Morgan Stanley upgraded its rating. Their new recommendation was “an Overweight” for DGX stock which previously was a “an Equal-weight”.
Analyzing DGX Stock Performance
On last trading session, Quest Diagnostics, Inc [NYSE: DGX] rose 0.20% to $179.04. The stock’s lowest price that day was $177.67, but it reached a high of $179.4728 in the same session. During the last five days, there has been a surge of approximately 3.49%. Over the course of the year, Quest Diagnostics, Inc shares have jumped approximately 19.91%. Shares of the company reached a 52-week high of $182.38 on 06/16/25 and a 52-week low of $148.70 on 01/16/25.
Support And Resistance Levels for Quest Diagnostics, Inc (DGX)
According to the 24-hour chart, there is a support level at 177.93, which, if violated, would cause prices to drop to 176.82. In the upper region, resistance lies at 179.81. The next price resistance is at 180.58. RSI (Relative Strength Index) is 63.00 on the 14-day chart, showing neutral technical sentiment.
Is Quest Diagnostics, Inc subject to short interest?
Stocks of Quest Diagnostics, Inc saw a sharp steep in short interest on 2025-07-31 dropping by -0.24 million shares to 4.74 million. Data from Yahoo Finance shows that the short interest on 2025-06-30 was 4.98 million shares. A decline of -5.08% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 3.6 of the overall float, the days-to-cover ratio (short ratio) decline to 3.6.
Which companies own the most shares of Quest Diagnostics, Inc (DGX)?
In terms of Quest Diagnostics, Inc share price expectations, FactSet research, analysts set an average price target of 190 in the next 12 months, up nearly 6.34% from the previous closing price of $178.68. Analysts anticipate Quest Diagnostics, Inc stock to reach 195 by 2025, with the lowest price target being 185. In spite of this, 10 analysts ranked Quest Diagnostics, Inc stock as Buy at the end of 2025. On December 10, 2024, Jefferies assigned a price target of “a Buy” to the stock and resumed coverage with a $185.
